Zusammenfassung
Die biologischen Wissenschaften haben die Entwicklung in den letzten Jahrzehnten des vergangenen Jahrhunderts nachhaltig geprägt, und es wird erwartet, dass sich der rasante Erkenntniszuwachs im 21. Jahrhundert noch weiter beschleunigen wird. Die praktische Nutzung von Erkenntnissen aus der Biologie ist durch eine Reihe von methodischen Entwicklungen vorangetrieben worden. Hier ist an1. Stelle sicher die Gentechnik zu nennen, den 2. Platz nimmt zweifelsohne die Entwicklung der Hybridomtechnik (Köhler u. Mistein 1975) ein, die es erlaubt, Antikörper einer definierten Spezifität zu entwickeln.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ada GL, Nossal G (1987) The clonal-selection theory. Sci Am 257: 62–69
Alfthan K (1998) Surface plasmon resonance biosensors as a tool in antibody engineering. Biosens Bioelectron 13: 653–663
Andris-Widhopf J, Rader C, Steinberger P, Fuller R, Barbas CF 3rd (2000) Methods for the generation of chicken monoclonal antibody fragments by phage display. J Immunol Methods 242: 159–181
Ansell RJ, Ramstrom O, Mosbach K (1996) Towards artificial antibodies prepared by molecular imprinting. Clin Chem 42: 1506–1512
Asch RH, Asch B, Asch G, Asch M, Bray R, Rojas FJ (1988) Performance and sensitivity of modern home pregnancy tests. Int J Fertil 33:154, 157–158, 161
Asian M, Dent A (1998) Bioconjugation - Protein coupling techniques for the biomedical sciences. Macmillan, London
Barbas CF 3rd, Kang AS, Lerner RA, Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 88: 7978–7982
Bell S, Kamm MA (2000) Antibodies to tumour necrosis factor alpha as treatment for Crohn’s disease. Lancet 355: 858–860
Beste G, Schmidt FS, Stibora T, Skerra A (1999) Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold. Proc Natl Acad Sci USA 96: 1898–1903
Bhattacharya-Chatterjee M, Chatterjee SK, Foon KA (2000) Anti-idiotype vaccine against cancer. Immunol Lett 74: 51–58
Borrebaeck CA (2000) Antibodies in diagnostics–from immunoassays to protein chips. Immunol Today 21: 379–382
Böttger V, Peters L, Micheel B (1999) Identification of peptide mimotopes for the fluorescein hapten binding of monoclonal antibody B13–DE1. J Mol Recognit 12: 191–197
Breitling F, Dübel S (1997) Rekombinante Antikörper. Spektrum, Heidelberg Berlin
Bruggemann M, Taussig MI (1997) Production of human antibody repertoires in transgenic mice. Curr Opin Biotechnol 8: 455–458
Burnet FM (1959) The clonal selection theory of acquired immunity. Cambridge University Press, London
Cao Y, Suresh MR (1998) Bispecific antibodies as novel bio-conjugates. Bioconjug Chem 9: 635–644
Casey JL, Coley AM, Tilley LM, Foley M (2000) Green fluorescent antibodies: novel in vitro tools. Protein Eng 13: 445–452
Carter P (2001) Bispecific human IgG by design. J Immunol Methods 248: 7–15
Champlin R (1996) Purging: elimination of malignant cells from autologous blood or marrow transplants. Curr Opin Oncol 8: 79–83
Chapman AP, Antoniw P, Spitali M, West S, Stephens S, King DJ (1999) Therapeutic antibody fragments with prolonged in vivo half-lives. Nat Biotechnol 17: 780–783
Clackson T, Hoogenboom HR, Griffiths AD, Winter G (1991) Making antibody fragments using phage display libraries. Nature 352: 624–628
Cohen IR (1988) The self, the world and autoimmunity. Sci Am 258: 52–60
Davis CG, Gallo ML, Corvalan JR (1999) Transgenic mice as a source of fully human antibodies for the treatment of cancer. Cancer Metast Rev 18: 421–425
Deslys JP, Comoy E, Hawkins S et al. (2001) Screening slaughtered cattle for BSE. Nature 409: 476–478
Dimasi N, Martin F, Volpari C et al. (1997) Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires. J Virol 71: 7461–7469
Dordick JS (1988) Monoclonal antibodies for clinical applications. Patents and literature. Appl Biochem Biotechnol 19: 271–296
Duenas M, Chin LT, Malmborg AC, Casalvilla R, Ohlin M, Borrebaeck CA (1996) In vitro immunization of naive human B cells yields high affinity immunoglobulin G antibodies as illustrated by phage display. Immunology 89: 1–7
Duffy MJ (2001) Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 47: 624–630
Edelman GM (1970) The structure and function of antibodies. Sci Am 223: 34–42
Eshhar Z, Waks T, Bendavid A, Schindler DG (2001) Functional expression of chimeric receptor genes in human T cells. J Immunol Methods 248: 67–76
Farah RA, Clinchy B, Herrera L, Vitetta ES (1998) The development of monoclonal antibodies for the therapy of cancer. Crit Rev Eukaryot Gene Expr 8: 321–356
Galfré G, Milstein C (1981) Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 73: 3–46
Galfré G, Howe SC, Milstein C, Butcher GW, Howard JC (1977) Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266: 550–552
Glennie MJ, Johnson PW (2000) Clinical trials of antibody therapy. Immunol Today 21: 403–410
Godfrey MA, Kwasowski P, Clift R, Marks V (1993) Assessment of the suitability of commercially available SpA affinity solid phases for the purification of murine monoclonal antibodies at process scale. J Immunol Methods 160: 97–105
Gramer MJ, Britton TL (2000) Selection and isolation of cells for optimal growth in hollow fiber bioreactors. Hybridoma 19: 407–412
Green LL (1999) Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J Immunol Methods 231: 11–23
Gurunathan S, Klinman DM, Seder RA (2000) DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18: 927–974
Hamers-Casterman C, Atarhouch T, Muyldermans S et al. (1993) Naturally occurring antibodies devoid of light chains. Nature 363: 446–448
Hanes J, Jermutus L, Plückthun A (2000a) Selecting and evolving functional proteins in vitro by ribosome display. Methods Enzymol 328: 404–430
Hanes J, Schaffitzel C, Knappik A, Plückthun A (2000b) Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat Biotechnol 18: 1287–1292
Harlow E, Lane D (1988) Antibodies - A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor
Harlow E, Lane D (1999) Using antibodies - A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor
Harrison RA, Moura-Da-Silva AM, Laing GD et al. (2000) Antibody from mice immunized with DNA encoding the carboxyl-disintegrin and cysteine-rich domain (JD9) of the haemorrhagic metalloprotease, Jararhagin, inhibits the main lethal component of viper venom. Clin Exp Immunol 121: 358–363
Hasholzner U, Stieber P, Meier W, Lamerz R (1997) Value of HAMA-determination in clinical practice–an overview. Anticancer Res 17: 3055–3058
Herzenberg LA, De Rosa SC (2000) Monoclonal antibodies and the FACS: complementary tools for immunobiology and medicine. Immunol Today 21: 383–390
Herzenberg LA, Sweet RG, Herzenberg LA (1976) Fluorescence-activated cell sorting. Sci Am 234: 108–117
Hlinak A, Schade R, Bartels T, Ebner D (1996) Das Huhn als Versuchstier and Quelle spezifischer Dotterantikörper. Erfahrungen zur Haltung, Immunisierung and Legeleistung. Tierärztl Umschau 51:402–408 Hoffman D, Hesselberth J, Ellington AD (2001) Switching
nucleic acids for antibodies. Nat Biotechnol 19:313–314 Holliger P, Winter G (1993) Engineering bispecific antibodies. Curr Opin Biotechnol 4: 446–449
Hombach A, Schneider C, Sent D et al. (2000) An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells. Int J Cancer 88: 115–120
Hoogenboom HR, Chames P (2000) Natural and designer binding sites made by phage display technology. ImmunoI Today 21: 371–378
Hudson PJ, Kortt AA (1999) High avidity scFv multimers; diabodies and triabodies. J Immunol Methods 231: 177–189
Irving RA, Coia G, Roberts A, Nuttall SD, Hudson PJ (2001) Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics. J Immunol Methods 248: 31–45
Jahn S, Kiessig S, Grunow R, Specht U, Mau H, Baehr R von (1986) Production of human monoclonal antibodies by heterohybridization of human B lymphocytes of the spleen with mouse myeloma cells. Z Gesamt Inn Med 41: 493–497
Jahn S, Walper A, Grunow R, Heym S, Volk HD, Baehr R von (1990) The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line. Allerg Immunol 36: 359–365
Jakobovits A (1994) YAC vectors. Humanizing the mouse genome. Curr Biol 4: 761–763
Janeway CA Jr, Travers P, Walport M, Capra JD (1999) Immunobiology - The system in health and disease, 4th edn. Current Biology Publications and Garland Publishing, London New York
Janson AK, Smith CI, Hammarstrom L (1995) Biological properties of yolk immunoglobulins. Adv Exp Med Biol 371 A: 685–690
Jencks WP (1986) Catalysis in chemistry and enzymology. McGraw-Hill, New York
Jermutus L, Honegger A, Schwesinger F, Hanes J, Plückthun A (2001) Tailoring in vitro evolution for protein affinity or stability. Proc Natl Acad Sci USA 98: 75–80
Jerne NK (1973) The immune system. Sci Am 229:52–60 Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol (Paris) 125 C: 373–389
Jerne NK, Roland J, Cazenave PA (1982) Recurrent idiotopes and internal images. EMBO J 1: 243–247
Karawajew L, Micheel B, Behrsing O, Gaestel M (1987) Bi-specific antibody-producing hybrid hybridomas selected by a fluorescence activated cell sorter. J Immunol Methods 96: 265–270
Karsten U, Stolley P, Walther I et al. (1988) Direct comparison of electric field-mediated and PEG-mediated cell fusion for the generation of antibody producing hybridomas. Hybridoma 7: 627–633
Kerschbaumer RJ, Hirschl S, Kaufmann A, Ibl M, Koenig R, Himmler G (1997) Single-chain Fv fusion proteins suitable as coating and detecting reagents in a double antibody sandwich enzyme-linked immunosorbent assay. Anal Biochem 249: 219–227
Kilpatrick KE, Danger DP, Hull-Ryde EA, Dallas W (2000) High-affinity monoclonal antibodies to PED/PEA-15 generated using 5 microg of DNA. Hybridoma 19: 297–302
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497
Kolesnikov AV, Kozyr AV, Alexandrova ES et al. (2000) Enzyme mimicry by the antiidiotypic antibody approach. Proc Natl Acad Sci USA 97: 13526–13531
Kramer A, Schneider-Mergener J (1998) Synthesis and screening of peptide libraries on continuous cellulose membrane supports. Methods Mol Biol 87: 25–39
Kuo MC, Sogn JA, Max EE, Kindt TJ (1985) Rabbit-mouse hybridomas secreting intact rabbit immunoglobulin. Mol Immunol 22: 351–359
Larrick JW, Yu L, Chen J, Jaiswal S, Wycoff K (1998) Production of antibodies in transgenic plants. Res Immunol 149: 603–608
Little M, Breitling F, Micheel B, Dübel S (1994) Surface display of antibodies. Biotechnol Adv 12: 539–555
Löffler A, Kufer P, Lutterbuse R et al. (2000) A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes. Blood 95: 2098–2103
Mäkelä PH (2000) Vaccines, coming of age after 200 years. FEMS Microbiol Rev 24: 9–20
Mallender WD, Voss EW Jr (1995) Primary structures of three Armenian hamster monoclonal antibodies specific for idiotopes and metatopes of the monoclonal anti–fluorescein antibody 4–4–20. Mol Immunol 32: 1093 – 1103
Marasco WA (1995) Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy. Immunotechnology 1: 1–19
Matthey B, Engert A, Barth S (2000) Recombinant immunotoxins for the treatment of Hodgkin’s disease. Int J Mol Med 6: 509–514
Micheel B (1998) Tumorantigene and ihre Nutzung für eine Therapie von Tumoren. In:Ganten D, Ruckpaul K (Hrsg) Tumorerkrankungen. Springer, Berlin Heidelberg New York, S 160–185
Micheel B, Jantscheff P, Bottger V et al. (1988) The production and radioimmunoassay application of monoclonal antibodies to fluorescein isothiocyanate ( FITC ). J Immunol Methods 111: 89–94
Miltenyi S, Muller W, Weichel W, Radbruch A (1990) High gradient magnetic cell separation with MACS. Cytometry 11: 231–238
Milstein C (1980) Monoclonal antibodies. Sci Am 243:66–74 Milstein C (2000) With the benefit of hindsight. Immunol Today 21: 359–364
Milstein C, Waldmann H (1999) Optimism after much pessimism: what next? Curr Opin Immunol 11: 589–591
Moldenhauer G, Haustein D, Huppe T, Wagner A, Hartmann KU (1982) A new murine cell surface differentiation antigen (Leugp90) defined by a rat monoclonal antibody: cellular distribution and biochemical characterization. J Immunol 128: 2664–2669
Morgan CL, Newman DJ, Price CP (1996) Immunosensors: technology and opportunities in laboratory medicine. Clin Chem 42: 193–209
Murray JL (2000) Monoclonal antibody treatment of solid tumors: a coming of age. Semin Oncol 27: 64–70
Nguyen H, Sandhu J, Hozumi N (1997) Production of human monoclonal antibodies in SCID mouse. Microbiol Immunol 41: 901–907
Nishinaka S, Suzuki T, Matsuda H, Murata M (1991) A new cell line for the production of chicken monoclonal antibody by hybridoma technology. J Immunol Methods 139: 217–222
Nolte A, Klussmann S, Bald R, Erdmann VA, Furste JP (1996) Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nat Biotechnol 14: 1116–1119
Nossal GJ (1993) Life, death and the immune system. Sci Am 269: 52–62
Paul S (1998) Autoantibody catalysis: no longer hostage to Occam’s razor. Ann N Y Acad Sci 865: 238–246
Pollock DP, Kutzko JP, Birck-Wilson E, Williams JL, Echelard Y, Meade HM (1999) Transgenic milk as a method for the production of recombinant antibodies. J Immunol Methods 231: 147–157
Porter RR (1967) The structure of antibodies. Sci Am 217: 81–87
Queen C, Schneider WP, Selick HE et al. (1989) A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci USA 86: 10029–10033
Rabbany SY, Donner BL, Ligler FS (1994) Optical immunosensors. Grit Rev Biomed Eng 22: 307–346
Regenmörtel MH van, Pellequer JL (1994) Predicting antigenic determinants in proteins: looking for unidimensional solutions to a three-dimensional problem? Pept Res 7: 224–228
Riechmann L, Muyldermans S (1999) Single domain antibodies: comparison of camel VH and camelised human VH domains. J Immunol Methods 231: 25–38
Riethmuller G, Schneider-Gadicke E, Schlimok G et al (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes’ C colorectal carcinoma. German Cancer Aid 17–1A Study Group. Lancet 343: 1177–1183
Roitt I, Brostoff J, Male D (1998) Immunology, 5th edn. Mosby, St Louis
Sauerteig L (2000) Mit Chemie gegen die Syphilis–Anfänge der Chemotherapie um Paul Ehrlich und die DMW. Dtsch Med Wochenschr 125: 95–96
Sayegh CE, Drury G, Ratcliffe MI (1999) Efficient antibody diversification by gene conversion in vivo in the absence of selection for V(D)J-encoded determinants. EMBO J 18: 6319–6328
Schuhmacher J, Kaul S, Klivenyi G et al. (2001) Immunoscintigraphy with positron emission tomography: Gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies. Cancer Res 61: 3712–3717
Schuurs AH, Weemen BK van (1977) Enzyme-immunoassay. Clin Chim Acta 81: 1–40
Scott JK, Smith GP (1990) Searching for peptide ligands with an epitope library. Science 249: 386–390
Seetharaman S, Zivarts M, Sudarsan N, Breaker RR (2001) Immobilized RNA switches for the analysis of complex chemical and biological mixtures. Nat Biotechnol 19: 336341
Self CH, Cook DB (1996) Advances in immunoassay technology. Curr Opin Biotechnol 7: 60–65
Shu S, Plautz GE, Krauss JC, Chang AE (1997) Tumor immunology. JAMA 278: 1972–1981
Silverstein AM (1989) The history of immunology. In: Paul W (ed) Fundamental immunology, 2nd ed. Raven Press, New York, pp 21–38
Skerra A, Plückthun A (1988) Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240: 1038–1041
Spriel AB van, Ojik HH van, Winkel JG van de (2000) Immunotherapeutic perspective for bispecific antibodies. Immunol Today 21: 391–397
Stöcklein WFM, Rohde M, Scharte G et al. (2000) Sensitive detection of triazine and phenylurea pesticides in pure organic solvent by enzyme linked immunosorbent assay (ELISA): stabilities, solubilities and sensitivities. Anal Chim Acta 405: 255–265
Tada H, Kurokawa T, Seita T, Watanabe T, Iwasa S (1994) Expression and characterization of a chimeric bispecific antibody against fibrin and against urokinase-type plasminogen activator. J Biotechnol 33: 157–174
Tan LK, Oi VT, Morrison SL (1985) A human-mouse chimeric immunoglobulin gene with a human variable region is expressed in mouse myeloma cells. J Immunol 135: 3546–3547
Thrush GR, Lark LR, Clinchy BC, Vitetta ES (1996) Immunotoxins: an update. Annu Rev Immunol 14: 49–71
Tonegawa S (1993) The Nobel lectures in immunology. The Nobel Prize for Physiology or Medicine, 1987. Somatic generation of immune diversity. Scand J Immunol 38: 303–319
Verma R, Boleti E, George AJ (1998) Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. J Immunol Methods 216: 165–181
Wagner J, Lerner RA, Barbas CF 3rd (1995) Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes. Science 270: 1797–1800
Warren HS, Vogel FR, Chedid LA (1986) Current status of immunological adjuvants. Annu Rev Immunol 4: 369–388
Weber P, Weberova D, Martinek K (1988) Alpha-fetoprotein, carcinoembryonic antigen and various biochemical tests in patients with tumorous and inflammatory liver diseases. Neoplasma 35: 605–613
Weissman IL, Cooper MD (1993) How the immune system develops. Sci Am 269: 64–71
Wentworth P, Janda KD (1998) Catalytic antibodies. Curr Opin Chem Biol 2: 138–144
White CA, Weaver RL, Grillo-Lopez AJ (2001) Antibody-targeted immunotherapy for treatment of malignancy. Annu Rev Med 52: 125–145
Wilchek M, Bayer EA (1989) Avidin-biotin technology ten years on: has it lived up to its expectations? Trends Biochem Sci 14: 408–412
Williams AF (1979) Monoclonal antibodies in transplantation research. Transplantation 27: 152–155
Williams AF, Galfre G, Milstein C (1977) Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell 12: 663–673
Wood GS, Burns BF, Dorfman RF, Warnke RA (1986) In situ quantitation of lymph node helper, suppressor, and cytotoxic T cell subsets in AIDS. Blood 67: 596–603
Worn A, Plückthun A (2001) Stability engineering of antibody single-chain FIT fragments. J Mol Biol 305: 989–1010
Yan Z, Huang J (2000) Cleaning procedure for protein G affinity columns. J Immunol Methods 237: 203–205
Yano L, Shimura M, Taniguchi M et al. (2000) Improved gene transfer to neuroblastoma cells by a monoclonal antibody targeting RET, a receptor tyrosine kinase. Hum Gene Ther 11: 995–1004
Zamboni A, Giuntini I, Gianesello D, Maddalena F, Rognoni F, Herbst D (1994) Production of mouse monoclonal antibodies using a continuous cell culture fermenter and protein G affinity chromatography. Cytotechnology 16: 79–87
Zola H, Neoh SH (1989) Monoclonal antibody purification: choice of method and assessment of purity and yield. Biotechniques 7: 802, 804–808
Zusman RM, Ben-Hur H (2001) Serological markers for detection of cancer. Int J Mol Med 7: 547–556
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Micheel, B. (2003). Monoklonale Antikörper. In: Ganten, D., Ruckpaul, K. (eds) Grundlagen der Molekularen Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07588-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-07588-3_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-07589-0
Online ISBN: 978-3-662-07588-3
eBook Packages: Springer Book Archive